MSH6 and cancer: In our study, we excluded patients with familial cancer history, which included the high-penetrant Lynch families (those with MLH1 and MSH2 germline alternations), the remaining patients with lesser penetrant LS (those with MSH6 and PMS2 germline mutations) can be the reason for the high percentage of MSH6 loss in our study.